Abstract: The present invention relates to a food composition or health functional food containing prune. Consumption of the food composition or health functional food has the effect of preventing and alleviating low anterior resection syndrome.

Abstract: A cathode active material for a lithium secondary battery includes a lithium-transition metal oxide particle. A crystal index (CI) of the lithium-transition metal oxide particle is 15 or more. A lithium secondary includes a cathode including the cathode active material, and an anode facing the cathode. The cathode active material and the lithium secondary battery have improved operational reliability and thermal stability.

Abstract: A substrate transferring apparatus includes a support plate including an upper surface on which a substrate is configured to be seated, and a vacuum pad detachably coupled to the support plate and configured to vacuum suction the substrate to fix the substrate on the upper surface of the support plate, wherein the vacuum pad includes a suction area and a support protrusion surrounding the suction area, an upper surface of the support protrusion is at a higher vertical level than an upper surface of the suction area to support the substrate, and the upper surface of the support protrusion is inclined relative to horizontal.

Abstract: The invention discloses a loading optimization device and method for artificial intelligence models in an embedded environment. According to an embodiment of the present invention, the loading optimization method for artificial intelligence models in an embedded environment includes steps such as acquiring model information for the target model based on artificial intelligence, defining multiple partition scenarios for splitting the target model into multiple blocks based on the model information, and considering memory information of a computing device for executing the target model and computational workload information associated with the target model to explore the optimal scenario among the multiple partition scenarios through a reinforcement learning-based loading optimization model.

Abstract: A positive electrode active material according to an Example of the present invention may comprise a lithium layer doped with a first doping element and a transition metal layer doped with a second doping element, wherein an I(003)/I(006) peak intensity ratio in X-ray diffraction measurement is equal to or less than 23.8.

Abstract: Provided is a colorectal cancer-specific methylation biomarker for diagnosing colorectal cancer. Since a gene marker according to an embodiment exhibits a specific methylation pattern in colorectal cancer tissue, it can be usefully used as a methylation marker for diagnosing colorectal cancer, thereby increasing the cure rate of colorectal cancer by early diagnosis and treatment of colorectal cancer.

Abstract: A processing apparatus for a neural network calculation and an operating method thereof are proposed. The processing apparatus for a neural network calculation according to an exemplary embodiment includes a plurality of processor units which performs the learning of a neural network, a plurality of weight memories provided to store a weight corresponding to each of a plurality of layers which forms the neural network, and a main memory which acquires and stores the weight updated from the plurality of weight memories when the learning is completed.

Abstract: Provided are face recognition apparatus and method using a user terminal. The face recognition method using a user terminal includes acquiring image data including a facial region of a subject, acquiring face information which is encrypted to be stored in a user terminal of the subject, and determining whether an image of the facial region and the face information match each other.

Abstract: Provided is a colorectal cancer-specific methylation biomarker for diagnosing colorectal cancer. Since a gene marker according to an embodiment exhibits a specific methylation pattern in colorectal cancer tissue, it can be usefully used as a methylation marker for diagnosing colorectal cancer, thereby increasing the cure rate of colorectal cancer by early diagnosis and treatment of colorectal cancer.

Abstract: A decoding method of multi-view video information is provided. The decoding method of multi-view video information includes: receiving a bit stream about video data of a plurality of videos photographed by a plurality of cameras; generating first information by extracting depth information of a block in a video frame of a plurality of videos from video data included in the bit stream; generating second information by determining whether the same motion estimation is generated between video frames of the plurality of videos; generating third information by extracting pixel information of a block in the video frame of the plurality of videos; and performing block matching and disparity compensation between video frames of the plurality of videos by inputting the first information to third information to a disparity compensation model of multi-view video information which is generated by being trained in advance.

Abstract: A decoding method of multi-view video information is provided. The decoding method of multi-view video information includes: receiving a bit stream about video data of a plurality of videos photographed by a plurality of cameras; generating first information by extracting depth information of a block in a video frame of a plurality of videos from video data included in the bit stream; generating second information by determining whether the same motion estimation is generated between video frames of the plurality of videos; generating third information by extracting pixel information of a block in the video frame of the plurality of videos; and performing block matching and disparity compensation between video frames of the plurality of videos by inputting the first information to third information to a disparity compensation model of multi-view video information which is generated by being trained in advance.

Abstract: The present disclosure relates to a composition for diagnosis of liver metastasis of colorectal cancer and the use thereof, and more particularly to a composition for diagnosis of liver metastasis of colorectal cancer, which comprises either a substance for measuring the mRNA level of CCL7 (Chemokine (C-C motif) ligand 7) gene or a substance for measuring the level of a protein which is encoded by the gene. According to the present disclosure, whether liver metastasis of colorectal cancer occurred can be diagnosed by measuring the mRNA expression level of the CCL7 gene or the expression level of the CCL7 protein, and the use of the composition comprising an inhibitor of CCL7 gene allows the treatment of colorectal cancer or the liver metastasis of colorectal cancer.

Abstract: The present disclosure relates to a composition for diagnosis of liver metastasis of colorectal cancer and the use thereof, and more particularly to a composition for diagnosis of liver metastasis of colorectal cancer, which comprises either a substance for measuring the mRNA level of CCL7 (Chemokine (C-C motif) ligand 7) gene or a substance for measuring the level of a protein which is encoded by the gene. According to the present disclosure, whether liver metastasis of colorectal cancer occurred can be diagnosed by measuring the mRNA expression level of the CCL7 gene or the expression level of the CCL7 protein, and the use of the composition comprising an inhibitor of CCL7 gene allows the treatment of colorectal cancer or the liver metastasis of colorectal cancer.

Abstract: The present invention relates to a composition for diagnosis of liver metastasis of colorectal cancer and the use thereof, and more particularly to a composition for diagnosis of liver metastasis of colorectal cancer, which comprises either a substance for measuring the mRNA level of CCL7 (Chemokine (C-C motif) ligand 7) gene or a substance for measuring the level of a protein which is encoded by the gene. According to the present invention, whether liver metastasis of colorectal cancer occurred can be diagnosed by measuring the mRNA expression level of the CCL7 gene or the expression level of the CCL7 protein, and the use of the composition comprising an inhibitor of CCL7 gene allows the treatment of colorectal cancer or the liver metastasis of colorectal cancer.